|
Volumn 67, Issue 2, 2001, Pages 135-141
|
Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract
a a a a a |
Author keywords
Bladder tumor; Risk factor; Transitional cell carcinoma; Upper urinary tract tumor
|
Indexed keywords
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
FLUOROURACIL;
IFOSFAMIDE;
METHOTREXATE;
MITOMYCIN C;
PEPLEOMYCIN;
PIRARUBICIN;
VINBLASTINE;
ADULT;
AGED;
ARTICLE;
BLADDER CARCINOMA;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CYSTOSCOPY;
FEMALE;
FOLLOW UP;
GENDER;
HUMAN;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
NONBIOLOGICAL MODEL;
PATHOLOGY;
POSTOPERATIVE CARE;
PRIORITY JOURNAL;
RISK FACTOR;
TRANSITIONAL CELL CARCINOMA;
URETER SURGERY;
URINARY TRACT CARCINOMA;
ADULT;
AGED;
AGED, 80 AND OVER;
CARCINOMA, TRANSITIONAL CELL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASMS, SECOND PRIMARY;
RETROSPECTIVE STUDIES;
RISK FACTORS;
URETERAL NEOPLASMS;
URINARY BLADDER NEOPLASMS;
|
EID: 0034906218
PISSN: 00421138
EISSN: None
Source Type: Journal
DOI: 10.1159/000050969 Document Type: Article |
Times cited : (57)
|
References (23)
|